Literature DB >> 16288097

Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells.

Nina H Pipalia1, Amy Huang, Harold Ralph, Madalina Rujoi, Frederick R Maxfield.   

Abstract

Niemann-Pick disease type C (NPC) is an autosomal recessive genetic disorder manifested by abnormal accumulation of unesterified cholesterol and other lipids. We screened combinatorially synthesized chemical libraries to identify compounds that would partially revert cholesterol accumulation. Cultured CHO cells with NPC phenotypes (CT60 and CT43) were used for screening along with normal CHO cells as a control. We developed an automated microscopy assay based on imaging of filipin fluorescence for estimating cholesterol accumulation in lysosomal storage organelles. Our primary screen of 14,956 compounds identified 14 hit compounds that caused significant reduction in cellular cholesterol accumulation at 10 microM. We then screened a secondary library of 3,962 compounds selected based on chemical similarity to the initial hits and identified 7 compounds that demonstrated greater efficacy and lower toxicity than the original hits. These compounds are effective at concentrations of 123 nM to 3 microM in reducing the cholesterol accumulation in cells with a NPC1 phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288097     DOI: 10.1194/jlr.M500388-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

1.  Characterization of the Niemann-Pick C pathway in alveolar type II cells and lamellar bodies of the lung.

Authors:  Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Shaohui Huang; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-24       Impact factor: 5.464

2.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

3.  Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.

Authors:  Nina H Pipalia; Kanagaraj Subramanian; Shu Mao; Harold Ralph; Darren M Hutt; Samantha M Scott; William E Balch; Frederick R Maxfield
Journal:  J Lipid Res       Date:  2017-02-13       Impact factor: 5.922

4.  Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment.

Authors:  McKenna Feltes; Sarah E Gale; Samantha Moores; Daniel S Ory; Jean E Schaffer
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

5.  High-content screen for modifiers of Niemann-Pick type C disease in patient cells.

Authors:  Emily K Pugach; McKenna Feltes; Randal J Kaufman; Daniel S Ory; Anne G Bang
Journal:  Hum Mol Genet       Date:  2018-06-15       Impact factor: 6.150

6.  Fluorescence image screening for chemical compounds modifying cholesterol metabolism and distribution.

Authors:  Reiko Ishitsuka; Tamio Saito; Hiroyuki Osada; Yoshiko Ohno-Iwashita; Toshihide Kobayashi
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

7.  Generation of a human neuronal stable cell model for niemann-pick C disease by RNA interference.

Authors:  Laura Rodríguez-Pascau; Maria Josep Coll; Josefina Casas; Lluïsa Vilageliu; Daniel Grinberg
Journal:  JIMD Rep       Date:  2011-11-01

8.  Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.

Authors:  Carolina Courage; Karen L Oliver; Eon Joo Park; Jillian M Cameron; Kariona A Grabińska; Mikko Muona; Laura Canafoglia; Antonio Gambardella; Edith Said; Zaid Afawi; Betul Baykan; Christian Brandt; Carlo di Bonaventura; Hui Bein Chew; Chiara Criscuolo; Leanne M Dibbens; Barbara Castellotti; Patrizia Riguzzi; Angelo Labate; Alessandro Filla; Anna T Giallonardo; Geza Berecki; Christopher B Jackson; Tarja Joensuu; John A Damiano; Sara Kivity; Amos Korczyn; Aarno Palotie; Pasquale Striano; Davide Uccellini; Loretta Giuliano; Eva Andermann; Ingrid E Scheffer; Roberto Michelucci; Melanie Bahlo; Silvana Franceschetti; William C Sessa; Samuel F Berkovic; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2021-04-01       Impact factor: 11.025

Review 9.  Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.

Authors:  Paul Helquist; Frederick R Maxfield; Norbert L Wiech; Olaf Wiest
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

10.  Investigation of N-aryl-3-alkylidenepyrrolinones as potential Niemann-Pick type C disease therapeutics.

Authors:  Casey C Cosner; John T Markiewicz; Pauline Bourbon; Christopher J Mariani; Olaf Wiest; Madalina Rujoi; Anton I Rosenbaum; Amy Y Huang; Frederick R Maxfield; Paul Helquist
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.